SBC Medical Group Holdings Announces Final Results of Tender Offer for Waqoo, Inc. Shares

SBC Medical Group Holdings Incorporated (Nasdaq: SBC), a global provider of consulting and management services for medical organizations, has revealed the final results of its tender offer to acquire common shares of Waqoo, Inc. (Tokyo Stock Exchange Growth Market: 4937), a firm focused on regenerative medicine research and development. The tender offer ran from November 14 to December 12, 2025, with an offer price of ¥1,900 per share. SBC Medical will purchase 575,052 shares of Waqoo, with the settlement beginning on December 19, 2025. In addition to the tendered shares, Yoshiyuki Aikawa, Waqoo’s largest shareholder, is expected to transfer all his remaining shares to SBC Medical through an off‑market transaction effective the same day, increasing SBC Medical’s voting interest in Waqoo above 50% and making it the company’s parent and largest shareholder. The final results show that 637,817 shares were tendered, and the company will purchase the full planned volume of 575,052 shares on a pro‑rata basis due to oversubscription. Settlement will be in cash via SBI Securities Co., Ltd., with notifications mailed to participating shareholders after the tender offer period. The acquisition aligns with SBC Medical’s strategic growth plans, enhancing its healthcare technology capabilities and strengthening its presence in the Japanese market. #SlimScan #GrowthStocks #CANSLIM